CERS6 and metastatic malignant neoplasm in the lymph nodes: Among the examined genes, the expression of CERS6 was significantly elevated in NSCLC (Figure 1B) and also shown to be associated with poor patient prognosis (Figure 1C) as well as lymph node metastasis (Table 1).